Before 1962, US federal law did not require pre-marketing proof of effectiveness for drugs. But senate hearings revealing […]
The government’s plan to boost access to primary care by enhancing the role of community pharmacists offers the […]
A top cancer centre’s leadership rating has been downgraded from “outstanding” to “requires improvement” by the Care Quality […]
Key messagesComprehensive and appropriate community engagement is critical for quality improvement initiatives and improving health outcomes for communitiesToo […]
We have a great deal to learn from the period 1997 to 2005 when, as the King’s Fund […]
This paper by Pichler and colleagues (BMJ 2023;380:e072313, doi:10.1136/bmj-2022-072313, published 24 January 2023) has been corrected in several […]
NICE’s decision will result in eligible patients using a treatment that slows or halts aspects of the illness
The company intends to advance AF drugs that address current risk concerns with existing therapies
The number of children on the waiting list for consultant led paediatric treatment has reached an all time […]
